AstraZeneca Vaccine Suspended Over Blood Clot Concerns
Thirty thousand people will have their AstraZeneca vaccination appointments cancelled this week as a result of the clinical pause on its roll-out. Earlier we spoke to Paul Moynagh, Professor of Immunology about his reaction to the suspension and the risk it poses to public confidence in the vaccine rollout and for more we were joined on the show by Colm Henry Chief Clinical Officer with the HSE. Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify. Download, listen and subscribe on the Newstalk App. You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.